Delivery Order SPE2DB20D1100-SPE2DB25FC0F4

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $9.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,415.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, which provides a comprehensive global pharmaceutical support contract with a ceiling...
This federal contract award, valued at $7,967.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for the DLA, Defense...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAUA2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $30,816.53 and is a firm fixed-price delivery order, with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no...
This federal contract award, valued at $19,727.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. This contract is not set aside and was awarded through open competition. Amerisourcebergen Drug...
This federal contract award, valued at $3,784.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Nurtec ODT 75 mg tablets, a medication used for the treatment of migraines. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program and is open to competition. AmerisourceBergen...
This federal contract award, SPE2DB22D1202|SPE2DB25FUYJ9, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $25,478.68 firm fixed-price delivery order is for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has an ultimate completion date of April 21, 2025 and is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $27,277.47 and a completion date of September 20, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999...
This federal contract award, valued at $8,100.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Nurtec ODT 75 mg tablets, a neurological medication, with a performance period extending through April 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00. This IDC, designated as SPE2DX,...
This federal contract award, valued at $11,073.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the medication Nurtec ODT 75 mg Tablet 8s, a prescription treatment for migraine. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, valued at $21,024.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB25FUXEQ) under Amerisourcebergen's existing Indefinite Delivery Contract (SPE2DB25D3018) with DLA, which has a ceiling value of $999,999,999.00 and provides comprehensive global pharmaceutical support through December 2026. The current delivery order is for the supply of Nurtec ODT 75 mg...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC0F4
    Delivery Order

This federal contract award, SPE2DB20D1100|SPE2DB25FC0F4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set-aside, has an ultimate completion date of April 30, 2025 and a ceiling value of $9,499.29.

The award is for the delivery of Nurtec ODT 75 mg tablets, a prescription medication used for the treatment of migraine. As a delivery order contract, this award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle for the DLA, Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026.

Generated 7/29/25, 9:53 AM